New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
Rev. Soc. Bras. Med. Trop
;
49(1): 130-134, Jan.-Feb. 2016. tab
Artigo
em Inglês
| LILACS
| ID: lil-776530
ABSTRACT
Abstract New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Acinetobacter
/
Beta-Lactamases
/
Infecções por Acinetobacter
/
Infecção Hospitalar
/
Farmacorresistência Bacteriana Múltipla
/
Antibacterianos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
Medicina Tropical
Ano de publicação:
2016
Tipo de documento:
Artigo
País de afiliação:
Brasil
Instituição/País de afiliação:
Universidade do Sul de Santa Catarina/BR
Similares
MEDLINE
...
LILACS
LIS